Terms: = Ovarian cancer AND NUMA1, Q14980, 4926, ENSG00000137497, NUMA
6 results:
1. cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by
D'Ambrosio C; Erriquez J; Capellero S; Cignetto S; Alvaro M; Ciamporcero E; Di Renzo MF; Perera T; Valabrega G; Olivero M
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628590
[TBL] [Abstract] [Full Text] [Related]
2. Tankyrase as a Novel Molecular Target in cancer and Fibrotic Diseases.
Lakshmi TV; Bale S; Khurana A; Godugu C
Curr Drug Targets; 2017; 18(10):1214-1224. PubMed ID: 27425647
[TBL] [Abstract] [Full Text] [Related]
3. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
[TBL] [Abstract] [Full Text] [Related]
4. numa overexpression in epithelial ovarian cancer.
Brüning-Richardson A; Bond J; Alsiary R; Richardson J; Cairns DA; McCormac L; Hutson R; Burns PA; Wilkinson N; Hall GD; Morrison EE; Bell SM
PLoS One; 2012; 7(6):e38945. PubMed ID: 22719996
[TBL] [Abstract] [Full Text] [Related]
5. Tumor antigen acrosin binding protein normalizes mitotic spindle function to promote cancer cell proliferation.
Whitehurst AW; Xie Y; Purinton SC; Cappell KM; Swanik JT; Larson B; Girard L; Schorge JO; White MA
Cancer Res; 2010 Oct; 70(19):7652-61. PubMed ID: 20876808
[TBL] [Abstract] [Full Text] [Related]
6. Pegfilgrastim dosing on same day as myelosuppressive chemotherapy for ovarian or primary peritoneal cancer.
Schuman SI; Lambrou N; Robson K; Glück S; Myriounis N; Pearson JM; Lucci JA
J Support Oncol; 2009; 7(6):225-8. PubMed ID: 20380330
[TBL] [Abstract] [Full Text] [Related]
